1 January 2020 in Hypertension
Hypertension among young people is common, affecting 1 in 8 adults aged between 20 and 40 years. This number is likely to increase with lifestyle behaviors and lowering of hypertension diagnostic thresholds. Early-life factors influence blood pressure (BP) although the mechanisms are unclear; BP tracks strongly within individuals from adolescence through to later life. Higher BP at a young age is associated with abnormalities on heart and brain imaging and increases the likelihood of cardiovascular events by middle age. However, diagnosis rates are lower, and treatment is often delayed in young people. This reflects the lack of high-quality evidence that lowering BP in young adults improves cardiovascular outcomes later in life. In this review, we evaluate the current evidence regarding the association between BP in young adult life and adverse cardiovascular outcomes later in life. Following this, we discuss which young people with raised BP should be investigated for secondary causes of hypertension. Third, we assess the current models to assess cardiovascular risk and show a lack of validation in the younger age group. Fourth, we evaluate the evidence for lifestyle interventions in this age group and demonstrate a lack of persistence in BP lowering once the initial intervention has been delivered. Fifth, we address the pros and cons of drug treatment for raised BP in young people. Finally, there are unique life events in young people, such as pregnancy, that require specific advice on management and treatment of BP.
1 January 2014 in Microvascular Research
1 December 2016 in Journal of Cardiothoracic and Vascular Anesthesia
1 March 2012 in British Journal of Medical and Surgical Urology
Objective: To determine whether social deprivation influenced the rate of PSA testing per head of male population within the catchment area of our institution. Patients and methods: We retrospectively collated all PSA tests performed by general practitioners within an 18-month period in the catchment area of our institution (n = 10,695). PSA testing frequency within each lower super output area (LSOA) within the catchment area of our hospital was determined. The social deprivation of each LSOA was assessed using the Index of Multiple Deprivation 2007 index (IMD). Using these data, the percentage of men undergoing PSA tests in each LSOA was calculated as was the percentage of positive tests amongst those tested. Logistic regression analysis was performed with age and IMD 2007 scores as covariates. Results: Increasing IMD 2007 score was independently associated with a decreased likelihood of PSA testing (odds ratio 0.976 (95% confidence interval 0.959–0.994) p = 0.008). There was no association between IMD 2007 score and the rate of positive tests (odds ratio 0.997 (0.984–1.009) p = 0.60). Conclusions: Increasing levels of social deprivation demonstrate a small but significant association with a lower incidence of PSA testing in the catchment area of our institution. © 2011 British Association of Urological Surgeons. Published by Elsevier Ltd. All rights reserved.
4 September 2012 in Extreme Physiology & Medicine
Photosynthesis maintains aerobic life on Earth, and Joseph Priestly first demonstrated this in his eighteenth-century bell jar experiments using mice and mint plants. In order to demonstrate the fragility of life on Earth, Priestley's experiment was recreated using a human subject placed within a modern-day bell jar.
4 July 2023 in Journal of the American Heart Association
Background: An elevated ventilatory efficiency slope during exercise (minute ventilation/volume of expired CO 2 ; V E /VCO 2 slope) is a strong prognostic indicator in heart failure. It is elevated in people with heart failure with preserved ejection, many of whom have hypertension. However, whether the V E /VCO 2 slope is also elevated in people with primary hypertension versus normotensive individuals is unknown. We hypothesize that there is a spectrum of ventilatory inefficiency in cardiovascular disease, reflecting an increasingly abnormal physiological response to exercise. The aim of this study was to evaluate the V E /VCO 2 slope in patients with hypertension compared with age‐, peak oxygen consumption–, and sex‐matched healthy subjects. Methods and Results: Ramped cardiovascular pulmonary exercise tests to peak oxygen consumption were completed on a bike ergometer in 55 patients with primary hypertension and 24 normotensive controls. The V E /VCO 2 slope was assessed from the onset of exercise to peak oxygen consumption. Data were compared using unpaired Student t test. Age (mean±SD, 66±6 versus 64±6 years; P =0.18), body mass index (25.4±3.5 versus 24±2.4 kg/m 2 ; P =0.13), and peak oxygen consumption (23.2±6.6 versus 24±7.3 mL/min per kg; P =0.64) were similar between groups. The V E /VCO 2 slope was elevated in the hypertensive group versus controls (31.8±4.5 versus 28.4±3.4; P =0.002). Only 27% of the hypertensive group were classified as having a normal V E /VCO 2 slope (20–30) versus 71% in the control group. Conclusions: Ventilatory efficiency is impaired people with hypertension without a diagnosis of heart failure versus normotensive individuals. Future research needs to establish whether those patients with hypertension with elevated V E /VCO 2 slopes are at risk of developing future heart failure.